{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:17:50Z","timestamp":1761844670880},"reference-count":31,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.5632","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T22:10:35Z","timestamp":1468534235000},"page":"1853-1857","source":"Crossref","is-referenced-by-count":17,"title":["Serum Lipid Levels in Patients with Eating Disorders"],"prefix":"10.2169","volume":"55","author":[{"given":"Yoshikatsu","family":"Nakai","sequence":"first","affiliation":[{"name":"Kyoto Institute of Health Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun'ichi","family":"Noma","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Fukusima","sequence":"additional","affiliation":[{"name":"Division of Clinical Nutrition and Internal Medicine, Okayama Prefectural University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ataru","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Kyoto Preventive Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Teramukai","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Nakai Y, Nin K, Noma S. Epidemiological data on eating disorders in Japan. In: New Developments in Anorexia Nervosa Research. Gramaglia C, Zeppegno P, Eds. Nova Science Publishers, INC, New York, 2014: 173-187."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nakai Y, Nin K, Noma S. Eating disorder symptoms among Japanese female students in 1982, 1992 and 2002. Psychiatr Res 219: 151-156, 2014.","DOI":"10.1016\/j.psychres.2014.05.018"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry 19: 389-394, 2006.","DOI":"10.1097\/01.yco.0000228759.95237.78"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Di Cola G, Jacoangeli F, Jacoangeli F, Lombardo M, Iellamo F. Cardiovascular disorders in anorexia nervosa and potential therapeutic targets. Intern Emerg Med 9: 717-721, 2014.","DOI":"10.1007\/s11739-014-1107-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nakai Y, Nin K, Noma S, Hamagaki S, Takagi R, Wonderlich SA. Outcome of eating disorders in a Japanese sample: A 4- to 9-year follow-up study. Eur Eat Disord Rev 22: 206-211, 2014.","DOI":"10.1002\/erv.2290"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Casiero D, Frishman WH. Cardiovascular complications of eating disorders. Cardiol Rev 14: 227-231, 2006.","DOI":"10.1097\/01.crd.0000216745.96062.7c"},{"key":"7","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","unstructured":"7. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.","journal-title":"JAMA The Journal of the American Medical Association","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Boekholdt SM, Arsenault BJ, Mora S, et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA 307: 1302-1309, 2012.","DOI":"10.1001\/jama.2012.366"},{"key":"9","unstructured":"9. Japan Atherosclerosis Society. Japan Atherosclerosis Society Guidelines for Prevention of Atherosclerosis Cardiovascular Diseases 2012. Japan Atherosclerosis Society, Tokyo, Japan, 2012 (in Japanese)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bannai C, Kuzuya N, Koide Y, et al. Assessment of the relationship between serum thyroid hormone levels and peripheral metabolism in patients with anorexia nervosa. Endocrinol Jpn 35: 455-462, 1988.","DOI":"10.1507\/endocrj1954.35.455"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ohwada R, Hotta M, Oikawa S, Takano K. Etiology of hypercholesterolemia in patients with anorexia nervosa. Int J Eat Disord 39: 598-601, 2006.","DOI":"10.1002\/eat.20298"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. First M, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I disorders - Patient edition (SCID\/P). In: Biometrics Research Department. New York State Psychiatric Institute, New York, 1995.","DOI":"10.1037\/t07827-000"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakai Y, Fukushima M, Taniguchi A, Nin K, Teramukai S. Comparison of DSM-IV versus proposed DSM-5 diagnostic criteria for eating disorders in a Japanese sample. Eur Eat Disorders Rev 21: 8-14, 2012.","DOI":"10.1002\/erv.2203"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association, Washington, DC, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Friedewald WT. Estimation of the concentration of LDL cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972.","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"16","unstructured":"16. Japan Atherosclerosis Society. Japan Atherosclerosis Society Guidelines for Prevention of Atherosclerosis Cardiovascular Diseases 2002. Japan Atherosclerosis Society, Tokyo, Japan, 2002 (in Japanese)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Klinefelter HF. Hypercholesterolemia in anorexia nervosa. J Clin Endocrinol 25: 1520-1521, 1965.","DOI":"10.1210\/jcem-25-11-1520"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nestel PJ. Cholesterol metabolism in anorexia nervosa and hypercholesterolemia. J Clin Endocrinol Metab 38: 325-328, 1974.","DOI":"10.1210\/jcem-38-2-325"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mordasini R, Klose G, Greten H. Secondary type II hyperlipoproteinemia in patients with anorexia nervosa. Metabolism 27: 71-79, 1978.","DOI":"10.1016\/0026-0495(78)90125-7"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mehler PS, Lezotte D, Eckel R. Lipid levels in anorexia nervosa. Int J Eat Disord 24: 217-221, 1998.","DOI":"10.1002\/(SICI)1098-108X(199809)24:2<217::AID-EAT11>3.0.CO;2-W"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Weinbrenner T, Zuger M, Jacoby GE, et al. Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholestrolaemia. Br J Nutr 9: 959-969, 2004.","DOI":"10.1079\/BJN20041151"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Case T, Lemieux S, Kennedy SH, Lewis GF. Elevated plasma lipids in patients with binge eating disorders are found only in those who are anorexic. Int J Eat Disord 25: 187-193, 1999.","DOI":"10.1002\/(SICI)1098-108X(199903)25:2<187::AID-EAT8>3.0.CO;2-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Vize CM, Coker S. Hypercholesterolemia in bulimia nervosa. Int J Eat Disord 15: 293-295, 1994.","DOI":"10.1002\/1098-108X(199404)15:3<293::AID-EAT2260150315>3.0.CO;2-U"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sullivan PF, Gendall KA, Bulik CM, Carter FA, Joyce PR. Elevated total cholesterol in bulimia nervosa. Int J Eat Disord 23: 425-432, 1998.","DOI":"10.1002\/(SICI)1098-108X(199805)23:4<425::AID-EAT10>3.0.CO;2-V"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Pauporte J, Walsh BT. Serum cholesterol in bulimia nervosa. Int J Eat Disord 30: 294-298, 2001.","DOI":"10.1002\/eat.1087"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Monteleone P, Santonastaso P, Pannuto M, et al. Enhanced serum cholesterol and TG levels in bulimia nervosa: relationships to psychiatric comorbidity, psychopathology and hormonal variables. Psychiatry Res 134: 267-273, 2005.","DOI":"10.1016\/j.psychres.2004.06.019"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Mitchell JE, King WC, Pories W, et al. Binge eating disorder and medical comorbidities in bariatric surgery candidates. Int J Eat Disord 48: 471-476, 2015.","DOI":"10.1002\/eat.22389"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Roehrig M, Masheb RM, White MA, Grillo CM. Dieting frequency in obese patients with binge eating disorder: Behavioral and metabolic correlates. Obesity 17: 689-697, 2009.","DOI":"10.1038\/oby.2008.600"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Carnier J, Sanches PL, da Silva PL, et al. Obese adolescents with eating disorders: analysis of metabolic and inflammatory status. Psychol Behav 105: 175-180, 2012.","DOI":"10.1016\/j.physbeh.2011.08.014"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kilgore M, Muntner P, Woolley JM, Sharma P, Bittner V, Rosenson RS. Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults. J Clin Lipidol 8: 86-93, 2014.","DOI":"10.1016\/j.jacl.2013.11.001"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Garcia-Rubira JC, Hidalgo R, Gomez-Barrado JJ, Romero D, Cruz Fernandez JM. Anorexia nervosa and myocardial infarction. Int J Cardiol 45: 138-140, 1994.","DOI":"10.1016\/0167-5273(94)90270-4"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/14\/55_55.5632\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:21:44Z","timestamp":1600906904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/14\/55_55.5632\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":31,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.5632","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}